EVIA Life Sciences Form D (2026)

Summary

The SEC Form D for EVIA Life Sciences, filed on 2026-11-02, reports $700,002 raised. The legal name on the form is EVIA Life Sciences Inc. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/2162667/000216266726000001/0002162667-26-000001-index.htm

Year of incorporation on the form: more than five years ago. Securities on the form: equity. That wording is not stored as a round type. Earlier Form D filings, if any, are not combined. The issuer city on the form is Tokyo. It is not stored as a headquarters.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified: 2026-11-03

1. https://www.sec.gov/Archives/edgar/data/2162667/000216266726000001/0002162667-26-000001-index.htm
   Type: sec filing. Accessed 2026-11-03.
   SEC Form D for EVIA Life Sciences Inc. EDGAR filing date 2026-11-02. Acceptance time on the index page: 2026-11-02 11:58:45. Signed 2026-11-02 by Kosuke Takishima, Chief Executive Officer. First sale 2026-10-23. A new notice, not an amendment. Total amount sold $700,002 of an offering amount of $5,498,154. 1 investor already invested. Issuer address city is Tokyo, Japan. Jurisdiction on the form: Delaware. Entity type on the form: Corporation. Year of incorporation on the form: more than five years ago. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. Securities on the form: equity. That wording is not stored as a round type. Related persons use the names in the issue. Earlier Form D filings, if any, are not combined.
2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-03/
   Type: other verified public source. Accessed 2026-11-03.
   Raise Track Update for 2026-11-03, Section 3. Lists EVIA Life Sciences in Japan, industry Biotechnology, amount raised $700,002.